Already a print subscriber? Activate your online access.
Browse our complete archive of Infectious Diseases summaries
What prophylactic dose should be recommended?
Both active drugs tested produced higher cure rates than placebo.
New risk factors have been added to the QRISK calculator.
Colonoscopy and fecal immunochemical test are first-tier screening modalities.
Weight loss and several measure of cardiovascular risk were similar in both groups.
A single-center study showed remarkable mortality reduction with this cocktail.
The meningococcal B vaccine appears to offer some cross protection against gonorrhea and is the first vaccine to show effectiveness against this primarily mucosal infection.
HIV-discordant couples — in which only one partner is HIV-infected — have several options for attempting to conceive while minimizing the uninfected partner's risk, the CDC reports in MMWR.
FDA approval gives us another option that should not be overused.
The Advisory Committee on Immunization Practices recommends a single dose of vaccine for certain adult travelers to areas with active cholera transmission.
A recent Cochrane Review paper on direct-acting antiviral therapy for hepatitis C virus leaves hepatologists perplexed, says Dr. Paul Sax.
Small changes have been made to human papillomavirus and meningococcal vaccination schedules.
Treatment options are limited, and supporting evidence generally is poor.
Recommendations on TB testing incorporate recent evidence on using an interferon-gamma release assay for latent TB and nucleic acid amplification testing for active TB.